| |
| |
|
| Insider
Information: |
Fuchs Henry J |
| Relationship: |
|
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
222,228 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,063,061 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
222,228 |
|
|
| Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDEA |
Ardea Biosciences Inc |
Director |
– • – |
2011-06-03 |
4 |
S |
$24.25 |
$72,746 |
D/D |
(3,000) |
10,416 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-04-01 |
4 |
S |
$25.45 |
$63,626 |
D/D |
(2,500) |
31,000 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2016-04-01 |
4 |
A |
$25.48 |
$9,988 |
D/D |
392 |
3,233 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2010-11-01 |
4 |
S |
$25.75 |
$62,721 |
D/D |
(2,435) |
31,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-02-01 |
4 |
S |
$25.76 |
$21,462 |
D/D |
(833) |
31,000 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2007-02-16 |
4 |
AS |
$26.10 |
$27,196 |
D/D |
(1,042) |
9,375 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2016-05-26 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
130,914 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2016-08-26 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
128,878 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2016-11-25 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
128,878 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-02-24 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
143,442 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-06-16 |
4 |
OE |
$26.49 |
$484,462 |
D/D |
14,397 |
150,819 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2017-09-15 |
4 |
OE |
$26.49 |
$507,050 |
D/D |
15,000 |
151,422 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-01-02 |
4 |
OE |
$26.49 |
$507,050 |
D/D |
15,000 |
148,976 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
• – – |
2018-04-02 |
4 |
OE |
$26.49 |
$337,851 |
D/D |
10,000 |
163,326 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2014-04-01 |
4 |
A |
$26.57 |
$9,990 |
D/D |
376 |
376 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2016-07-01 |
4 |
A |
$26.74 |
$9,974 |
D/D |
373 |
3,606 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-01-03 |
4 |
S |
$26.99 |
$22,485 |
D/D |
(833) |
31,000 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-04-20 |
4 |
S |
$27.00 |
$355,455 |
D/D |
(13,165) |
22,835 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2010-12-01 |
4 |
S |
$27.08 |
$22,587 |
D/D |
(834) |
31,000 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2015-07-01 |
4 |
A |
$27.34 |
$9,979 |
D/D |
365 |
2,089 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
• – – |
2011-07-01 |
4 |
AS |
$27.68 |
$69,200 |
D/D |
(2,500) |
36,455 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-02-22 |
4 |
OE |
$27.75 |
$853,192 |
D/D |
26,479 |
32,811 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2019-02-25 |
4 |
OE |
$27.75 |
$97,708 |
D/D |
3,521 |
9,853 |
0 |
- |
|
| GHDX |
Genomic Health Inc |
Director |
– • – |
2014-07-01 |
4 |
A |
$27.86 |
$9,974 |
D/D |
358 |
734 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
• – – |
2008-11-18 |
4 |
AS |
$28.00 |
$29,176 |
D/D |
(1,042) |
14,891 |
0 |
- |
|
294 Records found
|
|
Page 6 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
